Background Fibrodysplasia ossificans progressiva is an autosomal dominant disorder due to germline mutations of ACVR1/ALK2 causing progressive heterotopic endochondral ossifications. Evidence of central nervous system involvement has emerged only recently.
Methods We performed an observational cross-sectional brain MRI study in 13 patients (8 females, mean age 20 years), examining the relationship of clinical and neuroradiological findings.
Results All patients presented small asymptomatic lesions similar to hamartomas at the level of the dorsal medulla and ventral pons, associated with minor brainstem dysmorphisms and abnormal origin of the vestibulocochlear and facial nerves. The size of the brainstem lesions did not correlate with patient's age (p=0.061), age at first flare-up (p=0.733), severity of disability (p=0.194), history of head trauma (p=0.415) or hearing loss (p=0.237). The radiologic features and the absence of neurological symptoms were consistent with a benign process. Variable signal abnormalities and/or calcifications of the dentate nuclei were noted in all patients, while basal ganglia abnormalities were present in nine subjects. Brain calcifications positively correlated with patient's age (p<0.001) and severity of disability (p=0.002).
Conclusions Our data support the hypothesis that the effects of mutation of the ACVR1/ALK2 gene are extended to the central nervous system. Brainstem hamartomatous lesions and dysmorphisms, variably associated with dentate nucleus and basal ganglia signal abnormalities and/or calcifications, may represent useful disease hallmarks.
- Clinical genetics
- Fibrodysplasia Ossificans Progressiva
- Brain MRI
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Contributors Study concept and design: MS, MB and MDR; analysis and interpretation of data: MS, MB, DT, AR and SU; genetic analysis: RB and RR; statistical analysis: DT; drafting and revising the manuscript: MS, MB, DT, GM, SU, RB, RR, AR and MDR.
Funding This study was partially supported by funds from ‘Ricerca Corrente contributo per la ricerca intramuraria’—Ministero della Salute—Italy.
Competing interests None declared.
Patient consent Obtained.
Ethics approval Institutional Review Board of Gaslini Hospital.
Provenance and peer review Not commissioned; externally peer reviewed.